This Ro review covers the highest-scoring weight loss provider in our 2026 rankings — an 8.8/10. Ro sells only FDA-approved, brand-name GLP-1s like Wegovy and Zepbound, sourced through official Novo Nordisk and Eli Lilly channels. That is the cleanest supply chain you can buy online today.
The trade-off is cost. A $149/month membership sits on top of medication that gets pricier as your dose climbs. Below we break down every fee, how the process works, and where Ro’s 610 BBB complaints come from — so you know the real monthly bill before you sign up.
What Is Ro?
Ro is the consumer brand of Roman Health Ventures, Inc., a New York telehealth company headquartered at 625 6th Avenue in Manhattan. Zachariah Reitano, Saman Rahmanian, and Rob Schutz founded it in October 2017 as Roman, a men’s health service, before expanding into weight loss with the Ro Body program.
This is not a small startup. Ro raised a $500 million Series D in March 2021 at a $5 billion valuation, and its February 2022 round pushed the post-money figure to roughly $6.66 billion. It has operated at national scale for nearly nine years and has been BBB-accredited since 2018.
What Ro sells in July 2026 matters most: only FDA-approved, brand-name GLP-1 medications. The menu includes the Wegovy pen, the new Wegovy pill, Zepbound pens and single-dose vials, the Foundayo (orforglipron) pill, and off-label Ozempic. No compounded semaglutide or tirzepatide appears anywhere on its current pricing page.
That was not always true. Like most telehealth companies, Ro sold compounded semaglutide during the shortage years — and compounded GLP-1s are not FDA-approved. But the FDA declared the semaglutide shortage resolved on February 21, 2025, mass-compounding grace periods ended by May 2025, and Ro moved fully to brand-name supply. In April 2025, Novo Nordisk named Ro one of its first direct telehealth partners for NovoCare Pharmacy, and in January 2026 Ro became one of the first platforms to carry the Wegovy pill, the first FDA-approved oral GLP-1 for weight loss.
Ro Pricing in 2026
Ro splits your bill in two: a required membership, plus medication billed separately. Here are the cash prices we verified on Ro’s official pricing page in July 2026.
| Item | First Month | Ongoing Price |
|---|---|---|
| Ro Body membership | $39 | $149/mo (as low as $74/mo with annual prepay) |
| Wegovy pill (oral semaglutide) | $149 | $199–$299/mo |
| Foundayo pill (orforglipron) | $149 | $199–$299/mo |
| Wegovy pen (injectable) | $199 | $199–$399/mo |
| Zepbound KwikPen (tirzepatide) | $299 | $399–$449/mo |
| Ozempic (off-label, at pharmacy) | — | About $900–$1,100/mo without insurance |
Three pricing rules matter before you commit. First, prices rise with dose. Ro’s own FAQ states that Wegovy pricing increases at higher doses, so the $199 pen you start with can become $399/month by the time you reach the 2.4 mg maintenance dose. The Zepbound KwikPen climbs from $299 the first month to $399–$449/month after that.
Second, the advertised numbers are intro rates. The $149 first-month pill price and the $199 first-month pen price are new-patient offers, not the ongoing bill. A Prepay & Save option cuts up to $150/month off the highest Wegovy pen dose, but only with an annual commitment.
Third, the membership never goes away. At $149/month on the monthly plan, it adds $1,788 per year before any medication ships. Prepaying a full year drops it to about $74/month — Ro says that saves up to $900 annually. To Ro’s credit, the fee is charged only if a provider finds you eligible, and Ro says its cash medication prices match manufacturer-direct channels like LillyDirect, NovoCare, and TrumpRx. We found no refund or money-back guarantee on the pages we reviewed.
Here is the realistic math for cash payers: membership plus the lowest Wegovy pen dose runs about $348/month, and membership plus the top dose lands near $548/month. If you have insurance that covers GLP-1s, the picture changes completely — and that is where Ro earns its score.
How Ro Works
Ro’s process runs in five steps, all documented on its official site.
Step 1: Online questionnaire. You answer health questions online — no in-person visit — and get an eligibility decision within about 2 days. One requirement many people miss: Ro’s help center says you must have seen a healthcare provider within the last 3 years to use the service.
Step 2: Provider review. A licensed, Ro-affiliated clinician in your state reviews your answers and prescribes a GLP-1 if it is medically appropriate. Ro serves all 50 states plus Washington, D.C. A prescription is never guaranteed.
Step 3: Insurance check. Ro checks your coverage for free, and its insurance concierge files prior-authorization paperwork for you. Budget 2–3 weeks if a prior authorization is needed. With coverage, your medication may cost only a copay.
Step 4: Delivery. Cash-pay medication ships to your door, with the first dose typically arriving in under a week (Zepbound vials usually fill in 1–4 days). Insurance-covered medication is picked up at your local pharmacy, usually within about 2 weeks.
Step 5: Ongoing care. Membership includes 24/7 care-team access, unlimited provider messaging, regular check-ins, dose titration, and side-effect support.
Ro Review: What Results Can You Expect?
No honest Ro review can promise you a number — results come from the medication, not the website that ships it. In clinical trials, weekly semaglutide 2.4 mg (the Wegovy dose) produced an average 14.9% body-weight loss over 68 weeks in the STEP 1 trial. Tirzepatide (Zepbound’s molecule) reached up to 20.9% average loss over 72 weeks at the highest dose in SURMOUNT-1. Both trials paired medication with diet and exercise changes.
Ro’s own site claims members average 11–20% body-weight loss in one year, and it promotes celebrity testimonials from Serena Williams and Charles Barkley — keep in mind those endorsements are paid. Expect a slow ramp either way: the FDA’s Wegovy label titrates patients from 0.25 mg up to 2.4 mg over roughly four months, so meaningful weight loss builds gradually, not in week one.
Feedback on the service itself is mixed. Ro holds roughly 3.7/5 on Trustpilot across 2,300+ reviews, with praise for medication access and recurring complaints — echoed in BBB filings — about membership billing clarity and slow customer-service responses.
Ro vs Hers
Hers (8.5/10) is Ro’s closest rival: both now sell brand-name medication with a $149/month membership on top. Here is how they compare.
| Feature | Ro | Hers |
|---|---|---|
| Our score | 8.8/10 (Very Good) | 8.5/10 (Very Good) |
| Membership | $39 first month, then $149/mo | $39 first month, then $149/mo |
| Wegovy pen (cash) | $199 first month, then $199–$399/mo | From $199/mo |
| Oral options | Wegovy pill and Foundayo, $149 first month | Oral GLP-1 pills from $149/mo |
| Insurance support | Free check + concierge files prior authorizations | Less built out |
| BBB record | B rating, 610 complaints | A+ rating |
| Trustpilot | ~3.7/5 (2,300+ reviews) | ~3.8/5 (~7,000 reviews) |
| Regulatory record | No FDA warning letters found in our research | FDA warning letter Sept 2025; sued by Novo Nordisk Feb 2026 |
Ro wins on the two things that matter most in this category: supply chain and insurance help. Its NovoCare and LillyDirect integrations mean the medication comes through official manufacturer channels, and its concierge does the prior-authorization paperwork that most competitors leave to you. Hers counters with an A+ BBB grade, a slightly stronger Trustpilot record, and a women-focused experience — but its September 2025 FDA warning letter over compounded semaglutide marketing is a real blemish. Our full Hers review covers that history.
If brand-name pricing at either company feels steep, our roundup of Wegovy alternatives covers cheaper paths — including compounded options that cost less but are not FDA-approved.
Who Should Use Ro — and Who Shouldn’t
Use Ro if you have insurance that might cover GLP-1s. The free coverage check and prior-authorization concierge can turn a $548/month cash bill into a membership fee plus a copay. No other provider in our rankings supports insurance this well.
Use Ro if you refuse compounded drugs. Every product on Ro’s menu is FDA-approved and brand-name, sourced through manufacturer channels. If supply-chain safety is your top concern, the Ro weight loss program is the strongest option we have scored.
Use Ro if you want the newest oral options. Ro carries the Wegovy pill and the Foundayo (orforglipron) pill from $149 the first month — useful if you want to avoid needles, though both are cash-pay only.
Skip Ro if you are paying cash on a tight budget. Compounded semaglutide from other telehealth providers runs $99–$299/month with no membership fee — far below Ro’s realistic $350–$550 all-in cost. Those drugs are not FDA-approved, so weigh the savings honestly; our comparison of the best weight loss injections lays out every option side by side.
Skip Ro if you want coaching built in. Ro includes provider messaging, but it is not a behavior-change program. Our Noom Med review covers a rival that bundles compounded medication with full psychology-based coaching from $129 the first month.
Standard qualification rules apply: telehealth providers generally require a BMI of 30+, or 27+ with a weight-related condition like high blood pressure or type 2 diabetes. Expect disqualification for a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or current pregnancy. Ro adds one extra gate: you must have seen a healthcare provider within the past 3 years.
Is Ro Legit? Our Verdict
Yes — Ro is legit, and at 8.8/10 (Very Good) it is the highest-scoring provider on this site. It is a real, nine-year-old company with a documented funding history, official partnerships with Novo Nordisk and Eli Lilly, clinicians licensed in all 50 states, and a medication menu with zero compounded products. For safety of supply, nobody we have researched does it better.
Legit does not mean flawless, and the problems are worth stating plainly. The BBB shows 610 complaints against Ro and grades it a B despite accreditation since 2018; the recurring theme is confusion about the membership fee and what it does and does not include. Trustpilot sits at a middling ~3.7/5. Medication prices rise with dose, the advertised rates are first-month intro offers, and we found no money-back guarantee. Budget cash payers can pay less than half Ro’s all-in price elsewhere — just not for FDA-approved, brand-name medication.
How This Ro Review Scored the Brand
Our score comes from the public 5-factor rubric on our How We Rank page: pricing transparency (30%), total cost (25%), safety and sourcing (20%), service flexibility (15%), and reputation (10%). Ro dominates the safety and sourcing category and publishes a genuinely clear dose-by-dose price table, but it loses points on total cost (the membership stacking) and reputation (the BBB complaint file). These are editorial ratings built from documented research — provider websites, BBB and Trustpilot records, and company announcements verified in July 2026 — not first-hand drug testing, and not paid placement. If you carry decent insurance or simply will not gamble on compounded drugs, Ro is the provider we would point you to first.